Limited efficacy of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 186, Issue , 2015, Pages 26-33

  Vasconcelos, Ines ^a   Olschewski, Jessica ^a   Braicu, Ioana ^a   Sehouli, Jalid ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adjuvant treatment; Borderline ovarian tumors; Chemotherapy; Implants; Platinum based treatment

Indexed keywords

PLATINUM DERIVATIVE; ANTINEOPLASTIC AGENT;

ABDOMINAL HYSTERECTOMY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; DRUG EFFICACY; FEMALE FERTILITY; FOLLOW UP; HUMAN; OMENTECTOMY; OVARY TUMOR; PERITONEAL BIOPSY; PRIORITY JOURNAL; REVIEW; SALPINGOOOPHORECTOMY; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR RECURRENCE; ADJUVANT CHEMOTHERAPY; CANCER STAGING; FEMALE; HYSTERECTOMY; META ANALYSIS; MORTALITY; OVARIAN NEOPLASMS; OVARIECTOMY; PATHOLOGY; SALPINGECTOMY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; PLATINUM COMPOUNDS; SALPINGECTOMY; SURVIVAL RATE;

EID: 84923166341     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2014.12.022     Document Type: Review

References (43)

1. A.W. Kennedy, and W.R. Hart Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma Cancer 78 2 1996 278 286
2. J. Koern, C.G. Trope, and V.M. Abeler A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982: a review of clinicopathologic features and treatment modalities Cancer 1 71 1993 1810 1820
3. D.M. Gershenson, E.G. Silva, L. Levy, T.W. Burke, J.K. Wolf, and C. Tornos Ovarian serous borderline tumors with invasive peritoneal implants Cancer 82 6 1998 1096 1103
4. D.A. Bell, M.A. Weinstock, and R.E. Scully Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis Cancer 62 10 1988 2212 2222
5. R.E. Scully, and L.H. Sobin Histological typing of ovarian tumors. World Health Organization International Histological Classification of Tumors 2nd ed. 1999 Springer-Verlag Heidelberg
6. C. Trope, J. Kaern, I.B. Vergote, G. Kristensen, and V. Abeler Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors Gynecol Oncol 51 2 1993 236 243
7. G.P. Sutton, B.N. Bundy, and G.A. Omura ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study) Gynecol Oncol 41 3 1991 230 233
8. Y. Yokoyama, T. Moriya, and T. Takano Clinical outcome and risk factors for recurrence in borderline ovarian tumours Br J Cancer 94 11 2006 1586 1591
9. H.F. Wong, J.J. Low, Y. Chua, I. Busmanis, E.H. Tay, and T.H. Ho Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004 Int J Gynecol Cancer 17 2 2007 342 349
10. M. Akeson, B.M. Zetterqvist, K. Dahllof, A.M. Jakobsen, M. Brannstrom, and G. Horvath Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period Int J Gynecol Cancer 18 3 2008 453 459
11. K. Kokawa, Y. Mikami, and H. Sakata Clinical outcome and prognostic factors in borderline tumors of the ovary. Results from 17 years' experience in the Kinki District of Japan (1990-2006) Eur J Gynaecol Oncol 30 2 2009 155 161
12. J.Y. Park, D.Y. Kim, J.H. Kim, Y.M. Kim, Y.T. Kim, and J.H. Nam Surgical management of borderline ovarian tumors: the role of fertility-sparing surgery Gynecol Oncol 113 1 2009 75 82
13. T. Song, C.H. Choi, and H.S. Park Fertility-sparing surgery for borderline ovarian tumors: oncologic safety and reproductive outcomes Int J Gynecol Cancer 21 4 2011 640 646
14. S. Khunamornpong, J. Settakorn, K. Sukpan, P. Suprasert, and S. Siriaunkgul Mucinous tumor of low malignant potential ("borderline" or "atypical proliferative" tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion Int J Gynecol Pathol 30 3 2011 218 230
15. T. Song, Y.Y. Lee, and C.H. Choi Prognosis in patients with serous and mucinous stage I borderline ovarian tumors Int J Gynecol Cancer 22 5 2012 770 777
16. K. Tamakoshi, F. Kikkawa, and N. Nakashima Clinical behavior of borderline ovarian tumors: a study of 150 cases J Surg Oncol 64 2 1997 147 152
17. G. Zanetta, S. Rota, S. Chiari, C. Bonazzi, G. Bratina, and C. Mangioni Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study J Clin Oncol 19 10 2001 2658 2664
18. R. Fauvet, J. Boccara, C. Dufournet, E. David-Montefiore, C. Poncelet, and E. Darai Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study Cancer 100 6 2004 1145 1151
19. A. Ayhan, E.S. Guvendag Guven, S. Guven, and T. Kucukali Recurrence and prognostic factors in borderline ovarian tumors Gynecol Oncol 98 3 2005 439 445
20. M.S. Lenhard, S. Mitterer, and C. Kumper Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort Eur J Obstet Gynecol Reprod Biol 145 2 2009 189 194
21. A. du Bois, N. Ewald-Riegler, and N. de Gregorio Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynakologische Onkologie (AGO) Study Group Eur J Cancer 2013
22. M.G. Fort, V.K. Pierce, P.E. Saigo, W.J. Hoskins, and J.L. Lewis Jr. Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential Gynecol Oncol 32 3 1989 269 272
23. M. de Nictolis, R. Montironi, and S. Tommasoni Serous borderline tumors of the ovary. A clinicopathologic, immunohistochemical, and quantitative study of 44 cases Cancer 70 1 1992 152 160
24. J. Ren, Z. Peng, and K. Yang A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors Gynecol Oncol 110 2 2008 162 167
25. M.A. Rettenmaier, K. Lopez, L.N. Abaid, J.V. Brown 3rd, J.P. Micha, and B.H. Goldstein Borderline ovarian tumors and extended patient follow-up: an individual institution's experience J Surg Oncol 101 1 2010 18 21
26. J.Y. Park, D.Y. Kim, and J.H. Kim Micropapillary pattern in serous borderline ovarian tumors: does it matter? Gynecol Oncol 123 3 2011 511 516
27. D.M. Gershenson, and E.G. Silva Serous ovarian tumors of low malignant potential with peritoneal implants Cancer 65 3 1990 578 585
28. D.M. Gershenson, E.G. Silva, G. Tortolero-Luna, C. Levenback, M. Morris, and C. Tornos Serous borderline tumors of the ovary with noninvasive peritoneal implants Cancer 83 10 1998 2157 2163
29. R. Yazigi, A.K. Munoz, J. Sandstad, S. Lifshitz, and D.J. Choi Cisplatin based combination chemotherapy in the treatment of stage III ovarian epithelial tumors of low malignant potential Eur J Gynaecol Oncol 12 6 1991 451 455
30. R.R. Barakat, I. Benjamin, J.L. Lewis Jr., P.E. Saigo, J.P. Curtin, and W.J. Hoskins Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential Gynecol Oncol 59 3 1995 390 393
31. J.D. Seidman, and R.J. Kurman Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases Am J Surg Pathol 20 11 1996 1331 1345
32. K.A. Bell, A.E. Smith Sehdev, and R.J. Kurman Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas Am J Surg Pathol 25 4 2001 419 432
33. P. Morice, S. Camatte, and A. Rey Prognostic factors for patients with advanced stage serous borderline tumours of the ovary Ann Oncol 14 4 2003 592 598
34. E.G. Silva, D.M. Gershenson, A. Malpica, and M. Deavers The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent Am J Surg Pathol 30 11 2006 1367 1371
35. A. Leary, M.C. Petrella, and P. Pautier Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants Gynecol Oncol 132 1 2014 23 27
36. S.M. Gershenson The grim heritage of Lysenkoism: four personal accounts. IV. Difficult years in Soviet genetics Q Rev Biol 65 4 1990 447 456
37. Advanced Ovarian Cancer Trialists Group Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials BMJ 303 6807 1991 884 893
38. D.G. Allen, J. Baak, and D. Belpomme Advanced epithelial ovarian cancer: 1993 consensus statements Ann Oncol 4 Suppl. 4 1993 83 88
39. E.L. Trimble, and N.I.H. The Consensus conference on ovarian cancer: screening, treatment, and follow-up Gynecol Oncol 55 3 Pt 2 1994 S1 S3
40. A.L. Covens A critique of surgical cytoreduction in advanced ovarian cancer Gynecol Oncol 78 3 Pt 1 2000 269 274
41. W.E. Winter 3rd, G.L. Maxwell, and C. Tian Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study J Clin Oncol 26 1 2008 83 89
42. J.B. Trimbos, M. Parmar, and I. Vergote International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma J Natl Cancer Inst 95 2 2003 105 112
43. J.B. Trimbos, I. Vergote, and G. Bolis Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial J Natl Cancer Inst 95 2 2003 113 125